Conference Coverage: ESMO 2019 GU Highlights
Possible impact of recent select studies presented at ESMO on real-world clinical practice.
Faculty Chair
Daniel Petrylak, MD
Yale Cancer Center, New Haven, CT, USA
Report includes strategic recommendations and key takeaways on:
-
- Hormonal Approaches for Prostate Cancer
- Castration-Resistant Prostate Cancer – Targeted and Immunotherapies
- Updates in Renal Cell Carcinoma
- Novel Agents for Urothelial/Bladder Cancers
Attendees
Gerhardt Attard, MD, PhD
University College London, London, UK
Jorge A. García, MD
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
David Quinn, MD, PhD
University of Southern California, Los Angeles, CA, USA
Oliver Sartor, MD
Tulane University, New Orleans, LA, USA
Scott Tagawa, MD
Weill Cornell Medicine-Cornell University, New York, NY, USA
